Assessment of the methodological quality of case-control and cohort studies published in OA and non-OA journals using the Newcastle and Ottawa Scale (NOS).

<p>Assessment of the methodological quality of case-control and cohort studies published in OA and non-OA journals using the Newcastle and Ottawa Scale (NOS).</p

Proportion of adequate reporting according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) checklist of the systematic reviews and meta-analyses published in OA and non-OA journals.

<p>Proportion of adequate reporting according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) checklist of the systematic reviews and meta-analyses published in OA and non-OA journals.</p

Assessment of the methodological quality of systematic reviews and meta-analyses published in OA and non-OA journals using the Assessment of Multiple Systematic Reviews Scale (AMSTAR).

<p>Assessment of the methodological quality of systematic reviews and meta-analyses published in OA and non-OA journals using the Assessment of Multiple Systematic Reviews Scale (AMSTAR).</p

The search strategy and identification process of oncology journals and appraised studies.

<p>The search strategy and identification process of oncology journals and appraised studies.</p

Characteristics of the 85 studies evaluated published in oncology journals in 2013.

<p>Characteristics of the 85 studies evaluated published in oncology journals in 2013.</p

Proportion of adequate reporting according to the STROBE checklist of the case-control and cohort studies published in OA and non-OA journals using the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE).

<p>Proportion of adequate reporting according to the STROBE checklist of the case-control and cohort studies published in OA and non-OA journals using the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE).</p

Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic

COVID-19 pandemic has changed in-hospital care and was linked to superimposed infections. Here, we described epidemiology and risk factors for hospital-acquired bloodstream infections (HA-BSIs), before and during COVID-19 pandemic. This retrospective, observational, single-center real-life study included 14,884 patients admitted to hospital wards and intensive care units (ICUs) with at least one blood culture, drawn 48 h after admission, either before (pre-COVID, N = 7382) or during pandemic (N = 7502, 1203 COVID-19+ and 6299 COVID-19–). Two thousand two hundred and forty-five HA-BSI were microbiologically confirmed in 14,884 patients (15.1%), significantly higher among COVID-19+ (22.9%; ptrend p p p p p p p Acinetobacter spp. (0.16 × 100 patient-days) and Staphylococcus aureus (0.24 × 100 patient-days) peaked during the interval between first and second pandemic waves in our National context. Patients with HA-BSI admitted before and during pandemic substantially differed. COVID-19 represented a risk factor for HA-BSI, though not confirmed in the sole pandemic period. Some etiologies emerged between pandemic waves, suggesting potential COVID-19 long-term effect on HA-BSIs.</p